Biological Dynamics Appoints Irwin M. Jacobs as Chairman of the Board

“As our earliest investor and current Board member, Irwin has provided steadfast support and strategic guidance as Biological Dynamics transitions into a global commercial-stage company,” said Raj Krishnan, Ph.D., CEO of Biological Dynamics. “Now as Chairman, Irwin’s insight and expertise in both platform development and scaling up new businesses will continue to be invaluable as we advance our innovative molecular diagnostic platform for laboratory and point-of-care applications in oncology.”

“Biological Dynamics is developing technology that has the potential to fundamentally improve the way cancer is treated,” said Dr. Jacobs. “I am excited to take on the role of Chairman and work alongside the dedicated and talented team at Biological Dynamics to further support developing real-world applications of this innovative technology.”

Dr. Jacobs succeeds Dr. Paul R. Billings, who was recently appointed the Chief Medical Officer and Senior Vice President, Medical Affairs for Natera, following more than two years as Biological Dynamics’ Chairman. Since joining the Board, Dr. Billings’ input has been instrumental in strengthening the company’s team, operations, and clinical strategy.

As co-founder of Qualcomm, Dr. Jacobs led the commercialization of CDMA, a technology that brought advanced voice and data wireless communications to billions of consumers worldwide. Dr. Jacobs’ achievements in communications began at MIT, where he received his Doctor of Science degree in Electrical Engineering in 1959, and, while a faculty member from 1959-1966, coauthored the textbook Principles of Communication Engineering. He went on to serve as professor of Computer Science and Engineering at UCSD from 1966-1972 and cofounded and served as Chairman and CEO of Linkabit. He has received numerous recognitions and awards, including the National Medal of Technology, the IEEE Medal of Honor, the Franklin Institute Bower Award in Business Leadership, the IMEC Lifetime of Innovation Award, and nine honorary doctorates.

About Biological Dynamics

Biological Dynamics is an innovative diagnostic company committed to improving global cancer outcomes by empowering healthcare communities with accessible cancer diagnostics. Biological Dynamics’ proprietary technology platform, Verita™, isolates nanoparticles and macromolecules directly from whole blood, serum, or plasma without the need for pre-processing samples. The company is developing a portfolio of novel oncology products designed to enable early detection and individualized monitoring of cancer across multiple care settings, from cancer centers to physicians’ offices and retail clinics. In addition to lab-focused products, Biological Dynamics is also developing a smartphone-enabled portable version of the platform, with the goal of bringing blood-based DNA testing into the home. For more information visit us at www.biologicaldynamics.com and follow us at @BioynSD on Twitter.

View source version on businesswire.com: https://www.businesswire.com/news/home/20180620005416/en/